New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
How 40Hz sensory gamma rhythm stimulation clears amyloid in Alzheimer's mice

How 40Hz sensory gamma rhythm stimulation clears amyloid in Alzheimer's mice

by Massachusetts Institute of TechnologyBright staining highlights VIP-expressing interneurons in this coronal cross-section of a mouse brain. The neurons may help drive glymphatic clearance of a
Neurology March 08,2024
How 40Hz sensory gamma rhythm stimulation clears amyloid in Alzheimer's mice

How 40Hz sensory gamma rhythm stimulation clears amyloid in Alzheimer's mice

by Massachusetts Institute of TechnologyBright staining highlights VIP-expressing interneurons in this coronal cross-section of a mouse brain. The neurons may help drive glymphatic clearance of a
Neurology March 08,2024
Study finds the timing of CSF biomarker divergence for Alzheimer disease, normal cognition varies

Study finds the timing of CSF biomarker divergence for Alzheimer disease, normal cognition varies

by Elana GotkineCerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to
Neurology March 08,2024
Study finds the timing of CSF biomarker divergence for Alzheimer disease, normal cognition varies

Study finds the timing of CSF biomarker divergence for Alzheimer disease, normal cognition varies

by Elana GotkineCerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to
Neurology March 08,2024
Team develops highly accurate universal diagnostic blood test for Alzheimer's disease and mild cognitive impairment

Team develops highly accurate universal diagnostic blood test for Alzheimer's disease and mild cognitive impairment

by Hong Kong University of Science and TechnologyThe research team has developed a revolutionary blood test for Alzheimer’s disease (AD) that can measure the levels of 21 proteins in multiple cru
Neurology March 08,2024
Team develops highly accurate universal diagnostic blood test for Alzheimer's disease and mild cognitive impairment

Team develops highly accurate universal diagnostic blood test for Alzheimer's disease and mild cognitive impairment

by Hong Kong University of Science and TechnologyThe research team has developed a revolutionary blood test for Alzheimer’s disease (AD) that can measure the levels of 21 proteins in multiple cru
Neurology March 08,2024
Novel blood metabolite biomarkers linked to Alzheimer's disease

Novel blood metabolite biomarkers linked to Alzheimer's disease

by Lang Wu,University of Hawaii at ManoaFourteen metabolites whose genetically predicted levels in blood are associated with AD risk. The blood metabolites involved in amino acid, peptide, lipid
Neurology March 08,2024
Novel blood metabolite biomarkers linked to Alzheimer's disease

Novel blood metabolite biomarkers linked to Alzheimer's disease

by Lang Wu,University of Hawaii at ManoaFourteen metabolites whose genetically predicted levels in blood are associated with AD risk. The blood metabolites involved in amino acid, peptide, lipid
Neurology March 08,2024
Yoga provides unique cognitive benefits to older women at risk of Alzheimer's disease, study finds

Yoga provides unique cognitive benefits to older women at risk of Alzheimer's disease, study finds

by University of California, Los AngelesIdentification of genes with discordant expression following KY and MET at 12- and 24-weeks enriched for aging signatures.AStratified Rank-Rank
Neurology March 08,2024
Yoga provides unique cognitive benefits to older women at risk of Alzheimer's disease, study finds

Yoga provides unique cognitive benefits to older women at risk of Alzheimer's disease, study finds

by University of California, Los AngelesIdentification of genes with discordant expression following KY and MET at 12- and 24-weeks enriched for aging signatures.AStratified Rank-Rank
Neurology March 08,2024
Gut microbiome: Meet Asaccharobacter celatus—the brain health bug

Gut microbiome: Meet Asaccharobacter celatus—the brain health bug

by Nathan Nuzum,The ConversationCredit: Pixabay/CC0 Public DomainThere's a great deal of interest from scientists and the public alike in how we can keep our minds sharp and our brains healt
Neurology March 08,2024
Gut microbiome: Meet Asaccharobacter celatus—the brain health bug

Gut microbiome: Meet Asaccharobacter celatus—the brain health bug

by Nathan Nuzum,The ConversationCredit: Pixabay/CC0 Public DomainThere's a great deal of interest from scientists and the public alike in how we can keep our minds sharp and our brains healt
Neurology March 08,2024
AI finds key signs that predict patient survival across dementia types

AI finds key signs that predict patient survival across dementia types

byThe Mount Sinai HospitalSurvival Analysis Based On Dementia Subtypes. Credit: Zhang & Song et al., Communications MedicineResearchers at the Icahn School of Medicine at Mount Sinai and oth
Neurology March 08,2024
AI finds key signs that predict patient survival across dementia types

AI finds key signs that predict patient survival across dementia types

byThe Mount Sinai HospitalSurvival Analysis Based On Dementia Subtypes. Credit: Zhang & Song et al., Communications MedicineResearchers at the Icahn School of Medicine at Mount Sinai and oth
Neurology March 08,2024
Silent brain changes precede Alzheimer's. Researchers have new clues about which come first

Silent brain changes precede Alzheimer's. Researchers have new clues about which come first

by Lauran NeergaardA closeup of a human brain affected by Alzheimer's disease, is displayed at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y., on Oct. 7, 2003. According
Neurology March 08,2024
Silent brain changes precede Alzheimer's. Researchers have new clues about which come first

Silent brain changes precede Alzheimer's. Researchers have new clues about which come first

by Lauran NeergaardA closeup of a human brain affected by Alzheimer's disease, is displayed at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y., on Oct. 7, 2003. According
Neurology March 08,2024
Some older Americans show hesitation around brain scan research, study finds

Some older Americans show hesitation around brain scan research, study finds

by Rutgers UniversityCredit: Pixabay/CC0 Public DomainAsian Americans are less likely than their white peers to participate in health research involving MRIs and addressing this hesitancy could i
Neurology March 08,2024
Some older Americans show hesitation around brain scan research, study finds

Some older Americans show hesitation around brain scan research, study finds

by Rutgers UniversityCredit: Pixabay/CC0 Public DomainAsian Americans are less likely than their white peers to participate in health research involving MRIs and addressing this hesitancy could i
Neurology March 08,2024
Language barriers could contribute to higher aggression in people with dementia

Language barriers could contribute to higher aggression in people with dementia

by Edith Cowan UniversityPrevelance of each NPI domain for immigrants and non-immigrants. NPI: neuropsychiatric inventory. Differences between the groups at the .05 level and .001 level are marke
Neurology March 08,2024
Language barriers could contribute to higher aggression in people with dementia

Language barriers could contribute to higher aggression in people with dementia

by Edith Cowan UniversityPrevelance of each NPI domain for immigrants and non-immigrants. NPI: neuropsychiatric inventory. Differences between the groups at the .05 level and .001 level are marke
Neurology March 08,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com